InsidersTradesSigma
Track the Trillium Therapeutics Inc. stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Trillium Therapeutics Inc. has logged 6 insider filings. The latest transaction was disclosed on 19 November 2021 (Disposition). Among the most active insiders: Uger Robert. All data is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
2 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 November 2021
Declarations6 total
75 sharesCommon SharesSEC:0001104659-21-141749:0
5,736,363 shares0Common SharesSEC:0001209191-21-065762:0
3,646 shares@ US$0.303933.2% of flowCommon SharesSEC:0001062993-21-006419:0
3,646 shares@ US$0.31533.3% of flowCommon SharesSEC:0001062993-21-005487:0
87,500 shares@ US$0.4462100.0% of flowCommon SharesSEC:0001062993-21-004511:0
3,646 shares@ US$0.31333.4% of flowCommon SharesSEC:0001062993-21-004390:0
6 of 6 declarations
关于 Trillium Therapeutics Inc.
Trillium Therapeutics Inc. 是一家生物制药公司，专注于开发创新的癌症治疗方法。该公司致力于通过免疫学方法改善患者预后。
